test44
https://www.cytel.com/blog/leveraging-advanced-statistical-software-to-optimize-clinical-development
May 24, 2022
Traditionally, clinical trials are expensive, long in duration, and have low success rate. But with the advent of rich..
Read article
test44
https://www.cytel.com/blog/together-trial-wins-society-of-clinical-trials-david-sackett-trial-of-the-year-award
May 17, 2022
Early in the pandemic, it became clear that many of the COVID-19 therapies being tested in wealthier nations, were not..
Read article
test44
https://www.cytel.com/blog/cytel-australian-research-council-collaborate-to-strengthen-early-phase-capabilities
May 16, 2022
A combination of industry and policy forces have recently changed the shape of Australia’s R&D sector, making it a..
Read article
test44
https://www.cytel.com/blog/estimator-choice-in-synthetic-control-arm-analyses-an-ispor-podium-presentation-by-cytel
May 12, 2022
Synthetic control arm (SCA) methods are statistical methods that are seeing rapidly increasing use in comparative..
Read article
test44
https://www.cytel.com/blog/an-interview-with-grammati-sarri-on-moderating-an-issue-panel-at-ispor-us-2022-0
May 5, 2022
While randomized control trials remain the industry gold-standard for regulatory and reimbursement submissions, there..
Read article
test44
https://www.cytel.com/blog/optimizing-human-machine-partnership-for-up-to-date-evidence
May 4, 2022
If you are a pharmaceutical or biotech company seeking to enter the market with a new drug, you need to submit a..
Read article
test44
https://www.cytel.com/blog/adaptive-designs-for-early-phase-development-are-we-asking-the-right-questions
May 3, 2022
In 2005, Pfizer launched a Phase 1 trial for the kinase inhibitor crizotinib. Six years later, it was approved, thanks..
Read article
test44
https://www.cytel.com/blog/an-interview-with-gabriel-tremblay-on-his-poster-contributions-to-ispor-us-2022
April 29, 2022
At ISPOR US 2022, Cytel’s HEOR & RWE experts will be contributing to a range of Issue Panels, In-person Podium..
Read article
test44
https://www.cytel.com/blog/reinventing-clinical-trial-design-digital-development
April 27, 2022
New medicines and devices under development live and die on the strength of their clinical data. An asset’s journey is..
Read article
